New York, USA – November 22, 2022 – Currently, the outbreak of monkeypox continues to spread in over 48 countries, infecting over 35,000 population outside the continent of Africa. Hence, there is an urgent need for a more effective and rapid solution with outstanding treatment performance for monkeypox. Guided by profound experience and professional knowledge, Creative Biolabs is willing to and can quickly assist researchers in solving all problems encountered in monkeypox virus research by providing customers with access to a broad range of monkeypox products and accelerating their research progress. In order to actively encourage more in-depth research regarding monkeypox viruses, Creative Biolabs is introducing a 10% discount on all monkeypox products, valid until November 30, 2022.
Additionally, a portion of the monkeypox products offered by Creative Biolabs, including monkeypox plasmids, monkeypox primers and probes, monkeypox pseudoviruses, and monkeypox inhibitors, will be described in more detail.
“The utilization of linearized plasmids and polymerase chain reaction (PCR) assays can effectively assist in the detection of monkeypox viral DNA,” according to a scientist at Creative Biolabs.
Specialists at Creative Biolabs will not only provide diverse products related to monkeypox plasmids, primers, and probes but will also accelerate the overall monkeypox development process by supporting global researchers in this field. In addition to the aforementioned products, Creative Biolabs has also taken great efforts for product development based on monkeypox inhibitors and is dedicated to the innovation of additional products and moving researchers’ studies forward.
Based on a professional scientist team and advanced platforms, Creative Biolabs can provide a variety of high-quality monkeypox pseudovirus products to customers worldwide in a short order-to-delivery cycle, thereby expediting monkeypox virus testing and research. The pseudovirus, which boasts stability, quality, and convenient storage, can be utilized as a standard control for nucleic acid assays and poses no danger.
To learn more about monkeypox virus-related products at Creative Biolabs, please visit https://monkeypox.creative-biolabs.com.
About Creative Biolabs
Creative Biolabs, a biotech CRO company based in New York, United States, has successfully helped researchers from several nations address scientific and technical problems during the past several decades. With a professional scientific team and cutting-edge drug discovery platform, Creative Biolabs maintains its relevance to keep up with recent trends and strives to create innovative solutions to support large-scale research against emerging viruses or diseases.